Sun Pharma sumatriptan/naproxen recalled for failed dissolution
Sun Pharmaceutical Industries is recalling 3,453 bottles of 9-count sumatriptan and naproxen sodium tablets, 85 mg/500 mg. The tablets failed a dissolution test at the 12-month stability analysis, which measures how the tablet breaks down and releases its medicine. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Sun Pharmaceutical recalls
What to do
- Talk to your pharmacist or prescriber before stopping this medicine.
- Check the bottle for NDC 16714-891-01, lot DNG0559A, and expiration date 5/31/2027.
- The notice doesn't say how to get a refund or replacement; ask the pharmacy where you bought it.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Sumatriptan and Naproxen Sodium Tablets, 85mg/500mg, 9-count bottle, Rx only, Northstar Healthcase Holdings Ltd., NDC 16714-891-01.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
This recall covers 2 products — see all of them.
Details
- Units affected
- 3,453 bottles
- Illnesses reported
- None reported
- Manufactured in
- 2 Independence Way, Princeton, New Jersey, United States
- Classification
- Class II
- Recall number
- D-0187-2027
In the FDA's words
- Description
- Sumatriptan and Naproxen Sodium Tablets, 85mg/500mg, 9-count bottle, Rx only, Northstar Healthcase Holdings Ltd., NDC 16714-891-01. Failed Dissolution Specifications: (OOS) results was observed for dissolution Test during the analysis performed at the 12month Stability Lot: Lot DNG0559A, Expires: 5/31/2027 Distribution: Nationwide within the U.S Affected quantity: 3,453 bottles
- Hazard
- Failed Dissolution Specifications: (OOS) results was observed for dissolution Test during the analysis performed at the 12month Stability
2 products in this recall
Sun Pharma and Northstar sumatriptan-naproxen tablets recalled for dissolution failure
Sun Pharmaceutical is recalling 2 products of sumatriptan and naproxen sodium tablets, 85mg/500mg, in 9-count bottles, sold under the SUN PHARMA label and by Northstar Healthcare Holdings Ltd. Testing at the 12-month stability point found results that failed the tablets' dissolution specifications. The recall covers about 13,700 bottles distributed nationwide.
The agency lists each product separately. Check every one you might have.
- Sumatriptan and Naproxen Sodium Tablets, 85mg/500mg,9-count bottle, Rx only, SUN PHARMA, NDC 47335-410-22.D-0186-2027 · 10,296 bottles
- Sumatriptan and Naproxen Sodium Tablets, 85mg/500mg, 9-count bottle, Rx only, Northstar Healthcase Holdings Ltd., NDC 16714-891-01. (this page)D-0187-2027 · 3,453 bottles
More from Sun Pharmaceutical
See all- Sun Pharmaceutical lisdexamfetamine recalled for failed dissolution
ModerateFDANov 6, 2026
- Taro Tretinoin Cream 0.05% recalled for failed impurity specifications
ModerateFDAOct 14, 2026
- Sun nystatin cream recalled for failed stability specifications
ModerateFDASep 23, 2026
- Sun Pharmaceutical Carbamazepine 200mg tablets recalled for manufacturing defect
ModerateFDAAug 26, 2026